Synthesis of friedelan triterpenoid analogs with DNA topoisomerase IIα inhibitory activity and their molecular docking studiesMANDAL, Amitava; GHOSH, Shilpi; ASHIM KUMAR BOTHRA et al.European journal of medicinal chemistry. 2012, Vol 54, pp 137-143, issn 0223-5234, 7 p.Article

Recent Developments of DNA Poisons - Human DNA Topoisomerase IIα Inhibitors -as Anticancer AgentsPOGORELCNIK, Barbara; PERDIH, Andrej; SOLMAJER, Tom et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 13, pp 2474-2488, issn 1381-6128, 15 p.Article

A role for topoisomerase IIα in the formation of radiation-induced chromatid breaksTERRY, S. Y. A; RICHES, A. C; BRYANT, P. E et al.British journal of cancer. 2008, Vol 99, Num 4, pp 670-674, issn 0007-0920, 5 p.Article

Topoisomerase IIα maintains genomic stability through decatenation G₂ checkpoint signalingBOWER, J. J; KARACA, G. F; ZHOU, Y et al.Oncogene (Basingstoke). 2010, Vol 29, Num 34, pp 4787-4799, issn 0950-9232, 13 p.Article

Immunohistochemical study on topoisomerase IIα, Ki-67 and cytokeratin-19 in oral lichen planus lesionsMATTILA, Riikka; ALANEN, Kalle; SYRJÄNEN, Stina et al.Archives of dermatological research (Print). 2007, Vol 298, Num 8, pp 381-388, issn 0340-3696, 8 p.Article

Decreased topoisomerase IIα expression and altered histone and regulatory factors of topoisomerase IIα promoter in patients with chronic benzene poisoningKANG YU; SHI, Yi-Fen; YANG, Kai-Yan et al.Toxicology letters. 2011, Vol 203, Num 2, pp 111-117, issn 0378-4274, 7 p.Article

A Pilot Evaluation of a Novel Immunohistochemical Assay for Topoisomerase II-α and Minichromosome Maintenance Protein 2 Expression (ProEx C) in Cervical Adenocarcinoma In Situ, Adenocarcinoma, and Benign Glandular MimicsAXIMU, Dilinuer; AZAD, Azar; RUOYU NI et al.International journal of gynecological pathology. 2009, Vol 28, Num 2, pp 114-119, issn 0277-1691, 6 p.Article

Repair of idarubicin-induced DNA damage : A cause of resistance?DARTSCH, Dorothee C; GIESELER, Frank.DNA repair. 2007, Vol 6, Num 11, pp 1618-1628, issn 1568-7864, 11 p.Article

The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literaturesYUEYAO DU; QIONG ZHOU; WENJIN YIN et al.Breast cancer research and treatment. 2011, Vol 129, Num 3, pp 839-848, issn 0167-6806, 10 p.Article

The clinical relevance of the expression of several multidrug-resistant-related genes in patients with primary acute myeloid leukemiaGALIMBERTI, S; TESTI, R; GUERRINI, F et al.Journal of chemotherapy. 2003, Vol 15, Num 3, pp 374-379, issn 1120-009X, 6 p.Article

Validation of a novel immunocytochemical assay for topoisomerase II-α and minichromosome maintenance protein 2 expression in cervical cytologySHROYER, Kenneth R; HOMER, Petra; HEINZ, David et al.Cancer. 2006, Vol 108, Num 5, pp 324-330, issn 0008-543X, 7 p.Article

Human DNA Topoisomerase II-α expression in laparoscopically treated renal cell carcinomaDEKEL, Yoram; FREDE, Thomas; KUGEL, Valentina et al.Oncology reports. 2005, Vol 14, Num 1, pp 271-274, issn 1021-335X, 4 p.Article

Topoisomerase IIα expression in esophageal squamous cell carcinomaOHASHI, Y; SASANO, H; YAMAKI, H et al.Anticancer research. 1999, Vol 19, Num 3A, pp 1873-1880, issn 0250-7005Article

Biological properties of 4-methyl-2,7-diamino-5,10-diphenyl-4,9-diazapyrenium hydrogensulfate (ADAP)MARCZI, Saska; GLAVAS-OBROVAC, Ljubica; BELOVARI, Tatjana et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 4, pp 595-604, issn 0344-5704, 10 p.Article

Mechanisms of the formation of radiation-induced chromosomal aberrationsBRYANT, Peter E; RICHES, Andrew C; TERRY, Samantha Y. A et al.Mutation research. Genetic toxicology and environmental mutagenesis (Print). 2010, Vol 701, Num 1, pp 23-26, issn 1383-5718, 4 p.Conference Paper

Comparison of topoisomerase-IIα gene status between primary breast cancer and corresponding distant metastatic sitesDURBECQ, V; DI LEO, A; CARDOSO, F et al.Breast cancer research and treatment. 2003, Vol 77, Num 3, pp 199-204, issn 0167-6806, 6 p.Article

Sodium salicylate is a novel catalytic inhibitor of human DNA topoisomerase II alphaBAU, Jason T; KURZ, Ebba U.Biochemical pharmacology. 2011, Vol 81, Num 3, pp 345-354, issn 0006-2952, 10 p.Article

Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapyTSAVARIS, Nicolas; LAZARIS, Andreas; PATSOURIS, Efstathios et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 2, pp 391-398, issn 0344-5704, 8 p.Article

Targeting Her-2/neu in Breast Cancer : As Easy as This!AZIM, Hamdy; AZIM, Hatem A.Oncology. 2008, Vol 74, Num 3-4, pp 150-157, issn 0030-2414, 8 p.Article

A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase IIα, and TPX2): an immunohistochemical correlation, testing, and optimizing for mantle cell lymphomaBRIZOVA, Helena; KALINOVA, Marketa; KRSKOVA, Lenka et al.Virchows Archiv. 2010, Vol 456, Num 6, pp 671-679, issn 0945-6317, 9 p.Article

Inhibition of topoisomerase II α activity and induction of apoptosis in mammalian cells by semi-synthetic andrographolide analoguesNATEEWATTANA, Jintapat; SAEENG, Rungnapha; KASEMSOOK, Sakkasem et al.Investigational new drugs. 2013, Vol 31, Num 2, pp 320-332, issn 0167-6997, 13 p.Article

Correlation between topoisomerase-IIα gene amplification and protein expression in HER-2 amplified breast cancerDURBECQ, V; DESMEDT, C; LARSIMONT, D et al.International journal of oncology. 2004, Vol 25, Num 5, pp 1473-1479, issn 1019-6439, 7 p.Article

Topoisomerase IIα expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcomeSCHRADER, C; MEUSERS, P; BRITTINGER, G et al.Leukemia. 2004, Vol 18, Num 7, pp 1200-1206, issn 0887-6924, 7 p.Article

Topoisomerase IIα mRNA and protein expression vs. in vitro drug resistance and clinical outcome in acute leukaemiaUGGLA, Bertil; TINA, Elisabet; NAHI, Hareth et al.International journal of oncology. 2007, Vol 31, Num 1, pp 153-160, issn 1019-6439, 8 p.Article

Proliferative markers in diagnosis of thyroid tumors : A comparative study of MIB-1 and topoisomerase II-α immunostainingLUDVIKOVA, M; HOLUBEC, L. JR; RYSKA, A et al.Anticancer research. 2005, Vol 25, Num 3A, pp 1835-1840, issn 0250-7005, 6 p.Article